SAN DIEGO, Aug. 6, 2010 (GLOBE NEWSWIRE) -- Cytori Therapeutics (Nasdaq:CYTX) reports second quarter and first half 2010 financial results. Further details, including progress of the Company's commercial activities and product development pipeline, are provided in the 'August 2010 Shareholder Letter', which may be accessed at http://ir.cytoritx.com.
